CNS PHARMACEUTICALS INC (CNSP)

US18978H2013 - Common Stock

0.202  0 (-0.98%)

After market: 0.2081 +0.01 (+3.02%)

News Image
18 days ago - InvestorPlace

CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023

CNS Pharmaceuticals just reported results for the fourth quarter of 2023.

News Image
18 days ago - BusinessInsider

CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CNS Pharmaceuticals (NASDAQ:CNSP) just reported results for the fourth quarter ...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off trading on Tuesday with a look into the biggest pre-market stock movers traders need to keep an eye on today!

News Image
3 months ago - Seeking Alpha

CNS Pharmaceuticals prices $4M public offering (NASDAQ:CNSP)

CNS Pharmaceuticals announces public offering of 13.3 million shares at $0.30 per share, accompanied by Series A and Series B Warrants.

News Image
4 months ago - Seeking Alpha

CNS Pharmaceuticals files to sell 3.81M shares of common stock (NASDAQ:CNSP)

Read about CNS Pharmaceuticals' filing of a prospectus for the sale of 3.81M common stock.

News Image
5 months ago - Seeking Alpha

CNS Pharmaceuticals files to sell 3.76M shares of common stock for holders (NASDAQ:CNSP)

CNS Pharmaceuticals (CNSP) files prospectus for the offer and resale of 3.76M shares of common stock, but it is not an offer to sell.

News Image
9 months ago - Seeking Alpha

Moleculin investigating possible illegal trading of its shares (NASDAQ:MBRX)

Moleculin (MBRX) said that it has retained analytics firm Shareholder Intelligence Services, or ShareIntel, to investigate possible naked short selling of its shares. Read more here.

News Image
11 months ago - FinancialNewsMedia.com

Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer

/PRNewswire/ -- - The COVID-19 pandemic has had a limited impact on the global breast cancer therapeutics market and reports see substantial growth now that it...

News Image
11 months ago - FinancialNewsMedia

Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!